213 related articles for article (PubMed ID: 30854863)
21. Euthyroid Graves' orbitopathy and incidental papillary thyroid microcarcinoma.
Melcescu E; Horton WB; Pitman KT; Vijayakumar V; Koch CA
Hormones (Athens); 2013; 12(2):298-304. PubMed ID: 23933699
[TBL] [Abstract][Full Text] [Related]
22. The results of selective use of radioactive iodine on survival and on recurrence in the management of papillary thyroid cancer, based on Memorial Sloan-Kettering Cancer Center risk group stratification.
Nixon IJ; Ganly I; Patel SG; Palmer FL; Di Lorenzo MM; Grewal RK; Larson SM; Tuttle RM; Shaha A; Shah JP
Thyroid; 2013 Jun; 23(6):683-94. PubMed ID: 23742290
[TBL] [Abstract][Full Text] [Related]
23. Graves' thyrotoxicosis soon after hemithyroidectomy for low-risk papillary thyroid carcinoma.
Housin A; Tamilia M
BMJ Case Rep; 2022 May; 15(5):. PubMed ID: 35606042
[TBL] [Abstract][Full Text] [Related]
24. Radioactive Iodine for Papillary Thyroid Carcinoma.
Chan WWL; Kwong DLW
Methods Mol Biol; 2022; 2534():225-241. PubMed ID: 35670979
[TBL] [Abstract][Full Text] [Related]
25. Visual vignette.
Generoso JC; Hoang TD; Peterson B; Shwayhat AF
Endocr Pract; 2015 May; 21(5):557. PubMed ID: 25716639
[No Abstract] [Full Text] [Related]
26. Impact of Patient Age and Histological Type on Radioactive Iodine Avidity of Recurrent Lesions of Differentiated Thyroid Carcinoma.
Nakanishi K; Kikumori T; Miyajima N; Takano Y; Noda S; Takeuchi D; Iwano S; Kodera Y
Clin Nucl Med; 2018 Jul; 43(7):482-485. PubMed ID: 29688947
[TBL] [Abstract][Full Text] [Related]
27. [Radioactive iodine in the treatment of Graves' disease: history and modern concept of radionuclide therapy].
Sheremeta MS; Korchagina MO; Pesheva ED; Fadeev VV
Ter Arkh; 2022 Nov; 94(10):1211-1215. PubMed ID: 36468997
[TBL] [Abstract][Full Text] [Related]
28. Establishing a prediction model for lateral neck lymph node metastasis in patients with papillary thyroid carcinoma.
Jin S; Bao W; Yang YT; Bai T; Bai Y
Sci Rep; 2018 Nov; 8(1):17355. PubMed ID: 30478394
[TBL] [Abstract][Full Text] [Related]
29. Radioactive Iodine Ablation Decrease Recurrences in Papillary Thyroid Microcarcinoma with Lateral Lymph Node Metastasis in Chinese Patients.
Xue S; Wang P; Liu J; Chen G
World J Surg; 2017 Dec; 41(12):3139-3146. PubMed ID: 28741199
[TBL] [Abstract][Full Text] [Related]
30. Postoperative recurrence of papillary thyroid carcinoma with lymph node metastasis.
Liu FH; Kuo SF; Hsueh C; Chao TC; Lin JD
J Surg Oncol; 2015 Aug; 112(2):149-54. PubMed ID: 26175314
[TBL] [Abstract][Full Text] [Related]
31. A case of sarcoidosis and sarcoid granuloma, papillary carcinoma, and Graves' disease in the thyroid gland.
Zimmermann-Belsing T; Christensen L; Hansen HS; Kirkegaard J; Blichert-Toft M; Feldt-Rasmussen U
Thyroid; 2000 Mar; 10(3):275-8. PubMed ID: 10779143
[TBL] [Abstract][Full Text] [Related]
32. Fibro-hyaline involution of a papillary thyroid carcinoma metastasis in a lymph node, consecutive to radioiodine therapy, mimicking a parathyroid adenoma. A case presentation.
Deé E; Loghin A; Nechifor-Boilă A; Neagoe R; Paşcanu I; Borda A
Rom J Morphol Embryol; 2013; 54(4):1121-4. PubMed ID: 24399011
[TBL] [Abstract][Full Text] [Related]
33. Treatment of lateral neck papillary thyroid carcinoma recurrence after selective lateral neck dissection.
Strajina V; Dy BM; McKenzie TJ; Al-Hilli Z; Lee RA; Ryder M; Farley DR; Thompson GB; Lyden ML
Surgery; 2019 Jan; 165(1):31-36. PubMed ID: 30314726
[TBL] [Abstract][Full Text] [Related]
34. Inappropriate Use of Radioactive Iodine for Low-Risk Papillary Thyroid Cancer Is Most Common in Regions with Poor Access to Healthcare.
Marti JL; Davies L; Haymart MR; Roman BR; Tuttle RM; Morris LG
Thyroid; 2015 Jul; 25(7):865-6. PubMed ID: 25963001
[No Abstract] [Full Text] [Related]
35. Patients with Oncocytic Variant Papillary Thyroid Carcinoma Have a Similar Prognosis to Matched Classical Papillary Thyroid Carcinoma Controls.
Carr AA; Yen TWF; Ortiz DI; Hunt BC; Fareau G; Massey BL; Campbell BH; Doffek KL; Evans DB; Wang TS
Thyroid; 2018 Nov; 28(11):1462-1467. PubMed ID: 30215297
[TBL] [Abstract][Full Text] [Related]
36. Low risk papillary thyroid cancer.
Brito JP; Hay ID; Morris JC
BMJ; 2014 Jun; 348():g3045. PubMed ID: 24935445
[TBL] [Abstract][Full Text] [Related]
37. Radioactive iodine use in patients with low- and intermediate-risk papillary thyroid cancer.
Nixon IJ; Ganly I
Future Oncol; 2013 Jul; 9(7):921-3. PubMed ID: 23837752
[No Abstract] [Full Text] [Related]
38. Fine needle aspiration biopsy of the thyroid gland in patients with prior Graves' disease treated with radioactive iodine. Morphologic findings and potential pitfalls.
Centeno BA; Szyfelbein WM; Daniels GH; Vickery AL
Acta Cytol; 1996; 40(6):1189-97. PubMed ID: 8960027
[TBL] [Abstract][Full Text] [Related]
39. Papillary thyroid carcinoma arising from a thyroglossal duct cyst: a single institution experience.
Choi YM; Kim TY; Song DE; Hong SJ; Jang EK; Jeon MJ; Han JM; Kim WG; Shong YK; Kim WB
Endocr J; 2013; 60(5):665-70. PubMed ID: 23318645
[TBL] [Abstract][Full Text] [Related]
40. Ultrasonographic Features of the Major Salivary Glands after Radioactive Iodine Ablation in Patients with Papillary Thyroid Carcinoma.
Kim DW
Ultrasound Med Biol; 2015 Oct; 41(10):2640-5. PubMed ID: 26215493
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
